Dr. Kathy Signorelli has over 15 years of experience in medical and basic research within the pharmaceutical and biotech industries, as well as in academic centers. Her expertise encompasses a wide range of clinically relevant topics, including oncology, autoimmune diseases, tuberculosis, and vaccine development. Throughout her career, she has held several key positions, such as Director of Scientific Affairs at IRX Therapeutics, Inc., Project Scientist at the Cleveland Clinic Foundation's Lerner Research Institute, and Senior Staff Scientist at Genesis Research & Development Corp., Ltd. Additionally, she has worked as a Research Scientist at Marion Merrell Dow Pharmaceutical Co. and contributed to cancer research at the Centre Nationale de la Recherche Scientifique-LGME.

​

Dr. Signorelli has been instrumental in analyzing, interpreting, and applying scientific and medical information to advance research and development efforts. Her work has significantly impacted the understanding and treatment of various diseases, particularly in the fields of oncology and immunology. Her extensive experience and contributions to the scientific community have established her as a respected leader in her field, driving innovation and progress in medical research and development.